312 related articles for article (PubMed ID: 8142504)
1. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
[TBL] [Abstract][Full Text] [Related]
2. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
Derouin F
Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin prophylaxis and treatment of murine toxoplasmosis.
Tabbara KF; Hammouda E; Tawfik A; Al-Omar OM; Abu El-Asrar AM
Saudi Med J; 2005 Mar; 26(3):393-7. PubMed ID: 15806206
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
Costa IN; Angeloni MB; Santana LA; Barbosa BF; Silva MC; Rodrigues AA; Rostkowsa C; Magalhães PM; Pena JD; Silva DA; Mineo JR; Ferro EA
Placenta; 2009 Oct; 30(10):884-90. PubMed ID: 19703714
[TBL] [Abstract][Full Text] [Related]
5. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
Martins-Duarte ÉS; de Souza W; Vommaro RC
Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
[TBL] [Abstract][Full Text] [Related]
6. Nifurtimox plus pyrimethamine for treatment of murine toxoplasmosis.
Aguirre-Cruz L; Velasco O; Sotelo J
J Parasitol; 1998 Oct; 84(5):1032-3. PubMed ID: 9794648
[TBL] [Abstract][Full Text] [Related]
7. [In vitro effect of combined traditional Chinese medicine (Changqing capsule) on the tachyzoites of Toxoplasma gondii].
Zhang W; Fang FR; Liu YJ; Yang LD; Luo RY; Gong F; Lu H; Xu XX
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):56-8. PubMed ID: 16866146
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii.
Romand S; Pudney M; Derouin F
Antimicrob Agents Chemother; 1993 Nov; 37(11):2371-8. PubMed ID: 8285620
[TBL] [Abstract][Full Text] [Related]
9. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
Araujo FG; Shepard RM; Remington JS
Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the mood-stabilizing agent valproic acid as a preventative for toxoplasmosis in mice and activity against tissue cysts in mice.
Goodwin DG; Strobl J; Mitchell SM; Zajac AM; Lindsay DS
J Parasitol; 2008 Apr; 94(2):555-7. PubMed ID: 18564764
[TBL] [Abstract][Full Text] [Related]
11. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
Romand S; Bryskier A; Moutot M; Derouin F
J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of ponazuril in vitro and in preventing and treating Toxoplasma gondii infections in mice.
Mitchell SM; Zajac AM; Davis WL; Lindsay DS
J Parasitol; 2004 Jun; 90(3):639-42. PubMed ID: 15270113
[TBL] [Abstract][Full Text] [Related]
13. Lack of therapeutic effect of colchicine on murine toxoplasmosis.
Aguirre-Cruz L; Sotelo J
J Parasitol; 1998 Feb; 84(1):163-4. PubMed ID: 9488356
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine does not affect acute murine toxoplasmosis and is recommended as an analgesic in Toxoplasma gondii studies in mice.
Lindsay DS; Kaur T; Mitchell SM; Goodwin DG; Strobl J; Dubey JP
J Parasitol; 2005 Dec; 91(6):1488-90. PubMed ID: 16544426
[TBL] [Abstract][Full Text] [Related]
15. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
16. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of spiramycin in murine models of acute and chronic toxoplasmosis.
Grujić J; Djurković-Djaković O; Nikolić A; Klun I; Bobić B
Int J Antimicrob Agents; 2005 Mar; 25(3):226-30. PubMed ID: 15737517
[TBL] [Abstract][Full Text] [Related]
18. Toxoplasma gondii: effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo.
de Oliveira TC; Silva DA; Rostkowska C; Béla SR; Ferro EA; Magalhães PM; Mineo JR
Exp Parasitol; 2009 Jul; 122(3):233-41. PubMed ID: 19389400
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
Costa-Silva TA; Meira CS; Ferreira IM; Hiramoto RM; Pereira-Chioccola VL
Exp Parasitol; 2008 Nov; 120(3):227-34. PubMed ID: 18706414
[TBL] [Abstract][Full Text] [Related]
20. Toxoplasma gondii: fluconazole and itraconazole activity against toxoplasmosis in a murine model.
Martins-Duarte ES; Lemgruber L; de Souza W; Vommaro RC
Exp Parasitol; 2010 Apr; 124(4):466-9. PubMed ID: 20045696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
